Lidexa
PrescriptionHandelsnamen: Lidexa
About This Medication
DESCRIPTION Lidexa™ (Lidocaine Hydrochloride) Cream 38.8
Wirkstoffe
| Wirkstoff | Stärke |
|---|---|
| Lidocaine | - |
Indikationen und Anwendung
Dosierung und Verabreichung
Side Effects Overview
Warnhinweise und Vorsichtsmaßnahmen
WARNINGS For external use only. Not for ophthalmic use. Avoid contact with eyes. Excessive application may result in increased systemic absorption. Keep out of reach of children.
Kontraindikationen
CONTRAINDICATIONS Lidexa™ is contraindicated in patients with known hypersensitivity to lidocaine or any component of the formulation.
Frequently Asked Questions
INDICATIONS AND USAGE Lidexa™ is indicated for topical analgesia as directed by a healthcare provider.
DOSAGE AND ADMINISTRATION For topical use only. Apply to the affected area 3 to 4 times daily or as directed by a healthcare provider.
WARNINGS For external use only. Not for ophthalmic use. Avoid contact with eyes. Excessive application may result in increased systemic absorption. Keep out of reach of children.
CONTRAINDICATIONS Lidexa™ is contraindicated in patients with known hypersensitivity to lidocaine or any component of the formulation.
Lidexa is a prescription medication. You will need a valid prescription from a licensed healthcare provider.
Similar Topical Products
Browse all Topical products →References & Data Sources
- • DailyMed — Lidexa drug label (National Library of Medicine)
- • openFDA — Lidexa label data (U.S. Food & Drug Administration)
- • RxNorm — RXCUI 1723991 (NLM Normalized Drug Names)
- • NDC Directory — Lidexa (FDA National Drug Code)
Medizinischer Haftungsausschluss
Die Informationen auf dieser Seite dienen ausschließlich zu Bildungszwecken und sollten nicht als Ersatz für professionellen ärztlichen Rat, Diagnose oder Behandlung verwendet werden.
Wenden Sie sich bei Fragen zu einem medizinischen Zustand oder einem Arzneimittel stets an Ihren Arzt oder einen anderen qualifizierten Angehörigen der Gesundheitsberufe.
Datenquellen: DailyMed (NLM), openFDA, MFDS